A retrospective study evaluating signal intensity changes in the dentate nucleus after serial applications of gadolinium-based contrast agents.
Phase of Trial: Phase IV
Latest Information Update: 08 Mar 2017
At a glance
- Drugs Gadoterate-meglumine (Primary)
- Indications Multiple sclerosis
- Focus Diagnostic use
- 08 Mar 2017 New trial record